Terns Pharmaceuticals, Inc. Lease, Cost
Terns Pharmaceuticals, Inc. reported Lease, Cost of $496.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-03-30
- Terns Pharmaceuticals, Inc. lease, cost for the quarter ending 2025-12-31 was $127.00K, a 32.45% decline year-over-year.
- Terns Pharmaceuticals, Inc. lease, cost for the quarter ending 2025-09-30 was $129.00K, a 12.84% decline year-over-year.
- Terns Pharmaceuticals, Inc. lease, cost for the quarter ending 2025-06-30 was $131.00K, a 20.61% decline year-over-year.
- Terns Pharmaceuticals, Inc. lease, cost for the quarter ending 2025-03-31 was $109.00K, a 33.94% decline year-over-year.
- Terns Pharmaceuticals, Inc. lease, cost for fiscal 2025 was $496.00K, a 25.53% decline from fiscal 2024.
- Terns Pharmaceuticals, Inc. lease, cost for fiscal 2024 was $666.00K, a 0.15% increase from fiscal 2023.
- Terns Pharmaceuticals, Inc. lease, cost for fiscal 2023 was $665.00K, a 1.84% increase from fiscal 2022.
- Terns Pharmaceuticals, Inc. lease, cost for fiscal 2022 was $653.00K.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $127.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $256.00K derived: sum of 2 quarters · filed 2026-03-30 | $387.00K derived: sum of 3 quarters · filed 2026-03-30 | $496.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | $129.00K 10-Q · filed 2025-11-10 | $260.00K derived: sum of 2 quarters · filed 2025-11-10 | $369.00K 10-Q · filed 2025-11-10 | $557.00K derived: sum of 4 quarters · filed 2026-03-30 |
| 2025-06-30 | $131.00K 10-Q · filed 2025-08-05 | $240.00K 10-Q · filed 2025-08-05 | $428.00K derived: sum of 3 quarters · filed 2026-03-30 | $576.00K derived: sum of 4 quarters · filed 2026-03-30 |
| 2025-03-31 | $109.00K 10-Q · filed 2025-05-08 | $297.00K derived: sum of 2 quarters · filed 2026-03-30 | $445.00K derived: sum of 3 quarters · filed 2026-03-30 | $610.00K derived: sum of 4 quarters · filed 2026-03-30 |
| 2024-12-31 | $188.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $336.00K derived: sum of 2 quarters · filed 2026-03-30 | $501.00K derived: sum of 3 quarters · filed 2026-03-30 | $666.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | $148.00K 10-Q · filed 2025-11-10 | $313.00K derived: sum of 2 quarters · filed 2025-11-10 | $478.00K 10-Q · filed 2025-11-10 | $649.00K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $165.00K 10-Q · filed 2025-08-05 | $330.00K 10-Q · filed 2025-08-05 | $501.00K derived: sum of 3 quarters · filed 2025-08-05 | $665.00K derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $165.00K 10-Q · filed 2025-05-08 | $336.00K derived: sum of 2 quarters · filed 2025-05-08 | $500.00K derived: sum of 3 quarters · filed 2025-05-08 | $668.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $171.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $335.00K derived: sum of 2 quarters · filed 2025-03-20 | $503.00K derived: sum of 3 quarters · filed 2025-03-20 | $665.00K 10-K · filed 2025-03-20 |
| 2023-09-30 | $164.00K 10-Q · filed 2024-11-12 | $332.00K derived: sum of 2 quarters · filed 2024-11-12 | $494.00K 10-Q · filed 2024-11-12 | $657.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $168.00K 10-Q · filed 2024-08-05 | $330.00K 10-Q · filed 2024-08-05 | $493.00K derived: sum of 3 quarters · filed 2024-08-05 | $651.00K derived: sum of 4 quarters · filed 2024-08-05 |
| 2023-03-31 | $162.00K 10-Q · filed 2024-05-13 | $325.00K derived: sum of 2 quarters · filed 2024-05-13 | $483.00K derived: sum of 3 quarters · filed 2024-05-13 | $646.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $163.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $321.00K derived: sum of 2 quarters · filed 2024-03-14 | $484.00K derived: sum of 3 quarters · filed 2024-03-14 | $653.00K 10-K · filed 2024-03-14 |
| 2022-09-30 | $158.00K 10-Q · filed 2023-11-14 | $321.00K derived: sum of 2 quarters · filed 2023-11-14 | $490.00K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $163.00K 10-Q · filed 2023-08-08 | $332.00K 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | $169.00K 10-Q · filed 2023-05-15 |